Literature DB >> 16034623

Hyperbaric oxygen and sepsis: time to recognize.

Claus-Martin Muth, Peter Radermacher, Salvatore Cuzzocrea.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16034623     DOI: 10.1007/s00134-005-2700-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  30 in total

1.  Effect of hyperbaric oxygen on neutrophil CD18 expression.

Authors:  J L Larson; L L Stephenson; W A Zamboni
Journal:  Plast Reconstr Surg       Date:  2000-04       Impact factor: 4.730

2.  Functional inhibition of rat polymorphonuclear leukocyte B2 integrins by hyperbaric oxygen is associated with impaired cGMP synthesis.

Authors:  Q Chen; P D Banick; S R Thom
Journal:  J Pharmacol Exp Ther       Date:  1996-03       Impact factor: 4.030

3.  Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS.

Authors:  J A Buras; G L Stahl; K K Svoboda; W R Reenstra
Journal:  Am J Physiol Cell Physiol       Date:  2000-02       Impact factor: 4.249

4.  Iatrogenic cerebral air embolism: importance of an early hyperbaric oxygenation.

Authors:  P Blanc; A Boussuges; K Henriette; J M Sainty; M Deleflie
Journal:  Intensive Care Med       Date:  2002-03-21       Impact factor: 17.440

5.  Effects of hyperoxia on local and remote microcirculatory inflammatory response after splanchnic ischemia and reperfusion.

Authors:  Dan Waisman; Vera Brod; Rafael Wolff; Edmond Sabo; Mark Chernin; Zalman Weintraub; Avi Rotschild; Haim Bitterman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04-24       Impact factor: 4.733

6.  Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat.

Authors:  S Cuzzocrea; F Imperatore; G Costantino; C Luongo; E Mazzon; M A Scafuro; G Mangoni; A P Caputi; F Rossi; A Filippelli
Journal:  Shock       Date:  2000-03       Impact factor: 3.454

Review 7.  Evaluation and management of decompression illness--an intensivist's perspective.

Authors:  Kay Tetzlaff; Erik S Shank; Claus M Muth
Journal:  Intensive Care Med       Date:  2003-11-05       Impact factor: 17.440

8.  Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome.

Authors:  Francesco Imperatore; Salvatore Cuzzocrea; Carlo Luongo; Giovanni Liguori; Antonella Scafuro; Antonella De Angelis; Francesco Rossi; Achille P Caputi; Amelia Filippelli
Journal:  Intensive Care Med       Date:  2004-02-12       Impact factor: 17.440

9.  [Assessment of lipid peroxidation in hyperbaric oxygen therapy: protective role of N-acetylcysteine].

Authors:  P Pelaia; M Rocco; R A De Blasi; G Spadetta; D Alampi; F S Araimo; S Nicolucci
Journal:  Minerva Anestesiol       Date:  1995-04       Impact factor: 3.051

10.  Functional inhibition of leukocyte B2 integrins by hyperbaric oxygen in carbon monoxide-mediated brain injury in rats.

Authors:  S R Thom
Journal:  Toxicol Appl Pharmacol       Date:  1993-12       Impact factor: 4.219

View more
  4 in total

1.  Can (hyperbaric) oxygen turn off the motor of multiorgan dysfunction?

Authors:  Sükrü Oter; Peter Radermacher; Martin Matejovic
Journal:  Intensive Care Med       Date:  2006-09-30       Impact factor: 17.440

2.  Oxygen therapy for sepsis and prevention of complications.

Authors:  Hayk Minasyan
Journal:  Acute Crit Care       Date:  2022-03-17

3.  Hyperbaric oxygen therapy as a sole agent is not immunosuppressant in a highly immunogenic mouse model.

Authors:  Adam Gassas; Weixian Min; A Wayne Evans; Susan Carter; George K Sándor; Eyal Grunebaum
Journal:  Bone Marrow Res       Date:  2010-08-03

4.  Treatment with 24 h-delayed normo- and hyperbaric oxygenation in severe sepsis induced by cecal ligation and puncture in rats.

Authors:  Nina Falcon Bærnthsen; Marco Bo Hansen; Anna Mygind Wahl; Ulf Simonsen; Ole Hyldegaard
Journal:  J Inflamm (Lond)       Date:  2017-11-25       Impact factor: 4.981

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.